Valo Health Stock
Valo Health uses human-centric data and machine learning-anchored computation to transform the drug discovery and development process.
Sign up today and learn more about Valo Health Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Valo Health Stock
Valo Health, LLC (Valo) is a technology company that is using human-centric data and machine learning-anchored computation to transform the drug discovery and development process. By integrating data across the drug development lifecycle, the discovery and development of life-changing treatments can be accelerated, with the potential to reduce cost, time, and failure rate. The company's Opal Computational Platform™, a fully integrated, componentized, end-to-end drug development platform, offers a unique approach to therapeutic development, that enables Valo to advance a robust pipeline of candidates across cardiovascular disease, oncology, and neurodegeneration.
Funding History
July 2019 | $100M |
---|---|
January 2020 | $60.0M |
January 2021 | $190M |
March 2021 | $110M |
Management
Founder and CEO
David Berry
Chief Innovation Officer
Brett R. Blackman
Chief People Officer
Cissy Young
International Partnerships & Strategic Investment
Seth Williams
Investor
Ilya Rekhter
EVP & CFO
Graeme Bell
Chief Strategy Officer
Moni Miyashita
Board Member
David Epstein
Head of Corporate Communications
Jennifer Hanley
Executive Director, Business Development & External Innovation
Debra Peattie
Director Corporate Development
Zack Armen
VP of Innovation
Guido Lanza
Chief AI Officer
Brandon Allgood
Press
bioworld - Jan, 11 2024
Valo Health patents new PARP-1 inhibitorsendpts - Sep, 26 2023
Novo signs up for nearly a dozen cardiometabolic programs out of Valo Healthmedcitynews - Sep, 26 2023
Novo Nordisk Turns to Flagship’s Valo Health for AI-Driven Cardio Drug R&Dbizjournals - Sep, 25 2023
Valo Health enters $2.7B pact with Novo Nordisk to develop heart drugsmarketscreener - Sep, 25 2023
Novo Nordisk, Valo Health in Drug Discovery and Development Pact